AnalystsRoy Buchanan
Roy Buchanan's Stock Forecasts

Analyst Ranking
Top 2%
#65 out of 5192 analysts
Average Return
+92.78%
Win Rate
54%40 out of 74
Risk vs Reward
Poor
Good

Roy Buchanan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Abivax SaABVX
+1,693.10%$6.38$114.40
2025-01-10 -
2026-01-09
Buy
Cidara Therapeutics IncCDTX
+1,088.30%$18.63$221.38
2025-05-09 -
2026-01-06
Buy
Cidara Therapeutics IncCDTX
+948.20%$21.12$221.38
2025-04-29 -
2026-01-06
Buy
Cidara Therapeutics IncCDTX
+876.75%$22.67$221.38
2025-06-02 -
2026-01-06
Buy
Cidara Therapeutics IncCDTX
+862.52%$23.00$221.38
2025-03-12 -
2026-01-06
Buy

Roy Buchanan Analyst Color

Get additional color on Roy Buchanan's coverage of popular stocks

Roy Buchanan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cidara Therapeutics IncCDTX
8Buy$173.00-21.85%Maintains
4 months ago
Assembly Biosciences IncASMB
1Buy$38.00+42.54%Initiates Coverage On
5 months ago
Dynavax Technologies CorpDVAX
8Buy$32.00+106.45%Reiterates
6 months ago
Enanta Pharmaceuticals IncENTA
14Buy$25.00+80.51%Maintains
6 months ago
Polypid LtdPYPD
2Buy$14.00+216.03%Maintains
8 months ago
Curevac NvCVAC
9Buy$10.00+114.59%Reiterates
9 months ago
An2 Therapeutics IncANTX
8Buy$2.00+88.68%Maintains
9 months ago
Inovio Pharmaceuticals IncINO
3Buy$18.00+1,018.01%Reiterates
a year ago
Esperion Therapeutics IncESPR
3Buy$4.00N/AReiterates
a year ago
Ironwood Pharmaceuticals IncIRWD
1Buy$14.00N/AMaintains
a year ago
Abivax SaABVX
1Buy$33.00N/AReiterates
a year ago
Hookipa Pharma IncHOOK
2Buy$7.00N/AMaintains
a year ago
Gritstone Bio IncGRTSQ
4Buy$5.00N/AReiterates
2 years ago
Arbutus Biopharma CorpABUS
5Buy$5.00N/AMaintains
2 years ago
Pardes Biosciences IncPRDS
2Buy$5.00N/AMaintains
3 years ago
Argenx SeARGX
2Buy$448.00N/AMaintains
3 years ago
Cormedix IncCRMD
1Hold$16.00N/AMaintains
3 years ago
Ibio IncIBIO
1Buy$750.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.